Drug maker Novartis AG (NOVN.CH) is in advanced talks to acquire MorphoSys AG (MOR.DE), two people familiar with the matter told Reuters on Monday.
The sources added that there is no certainty that negotiations on the deal will be successful and asked to remain anonymous as the matter is confidential. They declined to provide any information on the acquisition price.
MorphoSys shares are currently gaining nearly 37%.

Source: xStation
Marvell Technology Anointed by Nvidia as the Next Chip Giant!
Oracle and Alphabet shares fall amid AI funding concerns 📉
CME Group shares fall amid selling pressure 🚩 Why it could be a warning sign for Wall Street?
Market Wrap: Europe is catching up🔼 Will Eurozone CPI data determine the ECB’s rate hike?